23andme is a consumer genetic testing company. The testing is not meant to be clinically applied. I work for a company that is similar to 23andme, different in the sense that the test can be clinically applied; the catch is that everything you report must be very robustly researched and you must comply with more regulation (research, lab, medical, security, etc.) which drives up the cost but gives you much more actionable and medically relevant information.
I think there are benefits to both approaches of genetic testing; 23andme has a lot of data it collects and can do interesting statistical studies/reporting that other more research-oriented companies cannot. However, like I said before, you can't view a test like that as medically actionable. In the end though, the more testing there is (as long as the messaging is clear and consumers do their homework), the better oFf the world will be.
I think there are benefits to both approaches of genetic testing; 23andme has a lot of data it collects and can do interesting statistical studies/reporting that other more research-oriented companies cannot. However, like I said before, you can't view a test like that as medically actionable. In the end though, the more testing there is (as long as the messaging is clear and consumers do their homework), the better oFf the world will be.